Prenetics Global LimitedPRE
Price$21.95

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $21.7M0.0% YoYTTM through 31 Dec 2024
Net Income -$49.8MTTM through 31 Dec 2024
Free Cash Flow -$29.9MTTM through 31 Dec 2024

Margins

Current
Gross Margin53.0%
Operating Margin-221.4%
Net Margin-229.1%

Returns

-22.9%ROE
-19.7%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio2.36x
Net Debt-$99.3Mnet cash position
Cash & Equivalents$52.3M

Quality Metrics

Piotroski F-Score3 / 9
FCF Margin-137.4%
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'20'21'22'23
FY2023: $21.7M
Diluted EPS
'20'21'22'23'24
FY2024: $-3.99

Dividend

No dividend

Capital Allocation

Capex Intensity4.6%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.